Pacemaker malfunctions in Danon's disease

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 1, 2008, Pages 125-128

  Marras, Elena ^a,b   Sciarra, Luigi ^a   Bocchino, Manuela ^a   Delise, Pietro ^a  

^a Santa Maria dei Battuti Hospital   (Italy)

^b NONE   (Italy)

Author keywords

Electrocardiogram; Pacing

Indexed keywords

GLYCOGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; DANON DISEASE; EYE MALFORMATION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PREEXCITATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MENTAL DEFICIENCY; MYOPATHY; PACEMAKER FAILURE; PRIMARY PREVENTION; SUDDEN DEATH; X CHROMOSOME LINKED DISORDER;

ADULT; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ELECTROCARDIOGRAPHY; EQUIPMENT FAILURE; GLYCOGEN STORAGE DISEASE TYPE IIB; HUMANS; MALE; RETREATMENT;

EID: 37549014193     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00937.x     Document Type: Article

References (16)

1. Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S, Schliselfeld LH. Lysosomal glycogen storage disease with normal acid maltase. Neurology 1981 31 : 51 57.
2. Ichizo Nishino, Jin Fu, Kurenai Tanji, Takeshi Yamada, Sadatomo Shimojok, Tateo Koori, Marina Mora, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000 406 : 906.
3. Mattei MG, Matterson J, Chen JW, Williams MA, Fukuda M. Two human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2, are encoded by genes localized to chromosome 13q34 and chromosome Xq24-25, respectively alanine aminotransferase levels compared with creatine. J Biol Chem 1990 265 : 7548 7551.
4. Charron P, Villard E, Sébillon P, Laforêt P, Maisonobe T, Duboscq-Bidot L, Romero N, et al. Danon's disease as a cause of hypertrophic cardiomyopathy: A systematic survey. Genet. 2004 41 : 751
5. Arad M, Maron BJ, Gorham JM, Johnson WH, Saul JP, Perez-Atayde AR, Spirito P, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005 352 : 362 372.
6. Yang Z, McMahon CJ, Smith LR, Bersola J, Adesina AM, Breinholt JP, Kearney DL, et al. Danon Disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation 2005 112 : 1612 1617.
7. Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, Riggs JE, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology 2002 58 : 1773 1778.
8. Packer DL. Complete heart block with myocardial membrane-bound glycogen and normal peripheral alpha-glucosidase activity. Ann. Intern: Med. 1988 109 : 985 987.
9. Charron P, Villard E, Sébillon P, Laforêt, Maisonobe, Duboscq-Bidot L, Romero N, et al. Danon disease as cause of hypertrophic cardiomyopathy: A systematic survey. Heart 2004 90 : 842 846.
10. Bulkley BH, Hutchins GM. Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome. Am Heart J 1978 96 : 246 252.
11. Jastrzebski M, Bacior B, Dimitrow PP, Kawecka-Jaszcz K. Electrophysiological study in a patient with Fabry disease and short PQ interval. Europace 2006 8 : 1045 1047.
12. Gollob MH, Green MS, Tang AS, Gallob T, Karibe A, Hassan AS, Ahamad F, et al. Identification of a gene responsible for familial Wolff-Parkinson-White Syndrome. N Engl J Med 2001 344 : 1823 1831.
13. Sidhu J, Roberts R. Genetic basis and pathogenesis of familial WPW syndrome. Indian Pacing Electrophysiol J 2003 3 : 197 201.
14. Gallob MH, Martin SG, Tang AS, Gallob T, Karibe A, Hassan A, Ahmad F, et al. Identification Of A Gene Responsible For Familial Wolff-Parkinson-White Syndrome. N Eng J Med 2001 344 : 1823 1831.
15. Sternick EB, Antonio O, Magalhães LP, Gerken LM, Hong K, Santana O, Brugada P, et al. Familial pseudo-Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol 2006 17 : 724 732
16. Arad M, Moskowitz IP, Patel VV, Ahmad F, Perez-Atayde AR, Sawyer DB, Walter M, et al. Define the cause of PRKAG2 transgenic mice overexpressing mutant. Circulation 2003 107 : 2850.